Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Tilray Brands, Inc. (TLRY)

2.5902 +0.0602 (+2.37%)
As of 11:16:43 AM EST. Market Open.
Trade TLRY on Coinbase
Chart Range Bar
Loading chart for TLRY

What's happening with TLRY?

16m ago
Powered by Yahoo Scout

Tilray Brands is consolidating Canadian cannabis operations while lifting the lower end of fiscal 2027 adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) guidance to $70 million, from $68 millionpreviously. Its latest quarter showed record revenue driven by beverages and pharmaceutical distribution, but cannabis sales declined and the company remained unprofitable.

Powered by Yahoo Scout
  • Previous Close 2.5300
  • Open 2.5700
  • Bid 1.9100 x 200
  • Ask 2.6200 x 100
  • Day's Range 2.5600 - 2.6600
  • 52 Week Range 2.4900 - 15.7000
  • Volume 1,824,503
  • Avg. Volume 4,026,126
  • Market Cap (intraday) 382.799M
  • Beta (5Y Monthly) 2.06
  • PE Ratio (TTM) --
  • EPS (TTM) -1.4100
  • Earnings Date (est.) Jan 7, 2027
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 5.72
  • Morningstar Rating Rating available with Stock Picks access

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and distributes pharmaceutical and wellness products; and produces, markets, and sells beverage products, and hemp-based food products. In addition, the company provides entertainment products. It offers its products under the Tilray, Aphria, Broken Coast, Symbios, Navcora, Tilray Craft, Charlotte's Web, Shock Top, Montauk Brewing, 10 Barrell, Breckenridge Brewery, SweetWater Brewing, Breckenridge Distillery, Blue Point, Alpine, Broken Coast, Redecan, XMG, Manitoba Harvest, CC Pharma, Good Supply, Solei, Mollo, Chowie Wowie, Original Stash, Canaca, RIFF, Tilray Medical, Bake Sale, The Batch, HEXO, Cruisies, Atwater Brewery, Hi-ball Energy, Liquid Love, Hop Valley Brewing, Redhook Brewery, Revolver Brewing, Square Mile Cider, Mock One, Widmer Brothers Brewing, Runner's High Brewing Company, SweetWater Brewing Company, Terrapin brands. The company sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. and changed its name to Tilray Brands, Inc. in January 2022. Tilray Brands, Inc. is headquartered in Leamington, Canada.

www.tilray.com

3,595

Full Time Employees

May 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

TLRY
71.32%
S&P 500 (^GSPC)
11.45%

1-Year Return

TLRY
80.67%
S&P 500 (^GSPC)
11.53%

3-Year Return

TLRY
85.77%
S&P 500 (^GSPC)
76.69%

5-Year Return

TLRY
97.51%
S&P 500 (^GSPC)
64.75%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY27
Revenue 257.15M
Earnings -40.03M
Profit Margin -15.57%

Q2

FY26

Q3

FY26

Q4

FY26

Q1

FY27

0
100M
200M
-20.0%
-18.0%
-16.0%
-14.0%

Analyst Insights

View More

Analyst Price Targets

4.00
5.72 Average
2.5902 Current
13.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 10/9/2026
Analyst Canaccord Genuity
Rating Action Maintains
Rating Hold
Price Action Lowers
Price Target 4.5 -> 4

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -17.05%

  • Return on Assets (ttm)

    -1.64%

  • Return on Equity (ttm)

    -9.38%

  • Revenue (ttm)

    963.1M

  • Net Income Avi to Common (ttm)

    -164.22M

  • Diluted EPS (ttm)

    -1.4100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    218.01M

  • Total Debt/Equity (mrq)

    23.15%

  • Levered Free Cash Flow (ttm)

    -16.63M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: